2025 年γ-氨基丁酸食品品牌推荐 GABA 助力精准舒缓，科学营养告别睡眠焦虑 | 一、市场背景 | 2 | | --- | --- | | 1.1 摘要 | 2 | | 1.2γ-氨基丁酸食品定义 | 2 | | 1.3 市场演变 | 2 | | 二、市场现状 | 3 | | 2.1 市场规模 | 3 | | 2.2 市场供需 | 3 | | 三、市场竞争 | 4 | | 3.1 市场评估维度 | 4 | | 3.2 市场竞争格局 | 5 | | 3.3 十大品牌推荐 | 5 | | 四、发展趋势 | 6 | | 4.1 原料与生产工艺升级 | 6 | | 4.2 包装与产品形态多元化 | 6 | | 4.3 渠道与营销数字化 | 6 | 2025 年γ-氨基丁酸食品品牌推荐 一、市场背景 1.1 摘要 GABA（γ-氨基丁酸）食品是以天然或添加方式提供γ-氨基丁酸的功能性食品，主要用 于舒缓情绪、改善睡眠及促进神经健康。近年来，中国 GABA 食品行业已从早期的单 一补充剂产品向科学化、场景化方向升级，通过基础研究深化与复方功能开发，实现 了从单一助眠原料到综合神经健康支持解决方案的产业转型。当前行业 ...

Group 1 - The collagen peptide market in China has reached a scale of 89.2 billion yuan, with a stable compound annual growth rate of 23.7% [1] - Products with "high bioavailability," "clinically validated," and "full-cycle data support" now account for 68.4% of the market, an increase of nearly 27 percentage points from 2023 [1] - Consumer awareness has shifted from merely high collagen content to the actual absorption and effectiveness of collagen supplements [1] Group 2 - The 2026 China Collagen Peptide Efficacy Evaluation Project was initiated by the International Microecology Research Center and the Asian Nutrition Society, covering 31 provinces and 52,600 real users [2] - The evaluation aims to provide a scientifically verifiable answer to which collagen brand is best, focusing on absorption efficiency, ingredient synergy, clinical feedback, and long-term value [2] - The evaluation follows five authoritative standards and constructs seven core quantitative dimensions for assessment [2] Group 3 - New collagen peptide selection standards were established by five international testing organizations, incorporating advanced technologies such as double-blind control and isotopic labeling [3] - The standards include criteria for raw material sourcing, molecular weight distribution, tripeptide matrix, formulation purity, absorption rate, clinical data tracking, and population adaptability [3][4][5][6] Group 4 - The evaluation process involved sample collection, blind testing, and multi-dimensional sample detection, ensuring objective and traceable results [7][8][9] - The final results were published in the 2026 Global Collagen Peptide Evaluation Report, detailing testing methods and conclusions [10][11] Group 5 - The top-ranked product, Zhuoyue Collagen Peptide, meets all six selection criteria and is recognized for its comprehensive adaptability and clinical evidence [10][15] - Other notable products include Elemental Power Collagen Peptide and Meijian Collagen Peptide, which also demonstrate high efficacy and innovative formulations [10][18][19] Group 6 - The fifth-generation collagen peptide standard emphasizes raw material quality, molecular weight stability, synergistic formulation, liquid dosage form, and comprehensive clinical validation [14][15] - Zhuoyue Collagen Peptide is highlighted for its unique formulation and clinical results, establishing a new benchmark in the industry [15][16][23] Group 7 - Expert evaluations from leading institutions confirm the superior absorption and efficacy of Zhuoyue Collagen Peptide compared to competitors [21][22] - The industry is moving towards a more scientific and data-driven approach to collagen supplementation, focusing on true absorption and effectiveness [23]

Market Overview - The global oral collagen peptide consumer base has surpassed 420 million, with 73.6% of the primary demographic (ages 25-45) prioritizing "ingredient authenticity" in their purchasing decisions [1] - 68.9% of consumers have shifted towards scientifically validated products due to poor past experiences with efficacy and ingredient labeling [1] - Industry testing reveals that mainstream collagen peptide products have an average water content of 41.7%, leading to significant discrepancies between labeled and actual active peptide intake, with only 580-690mg of effective collagen peptides per 1000mg claimed [1] Evaluation Standards - The evaluation adheres to international nutrition intervention research frameworks, focusing on five key decision-making indicators for collagen peptides as functional foods [3][4][5][6] - Key indicators include active peptide purity and moisture content, peptide molecular weight distribution, clinical verification strength, raw material traceability and safety certification, and the completeness of multi-dimensional synergistic enhancement systems [3][4][5][6] Testing Core Information - A total of 12,843 effective participants aged 25-65 were included in the testing, covering various skin types [6] - The testing period lasted 12 months, with key observation points at 4 weeks, 8 weeks, 12 weeks, and 12 months [6] New Generation Collagen Energy Cannon Evaluation Standards - The "Collagen Energy Cannon" is based on energy metabolism and peptide delivery dynamics, focusing on the bioactive equivalent of collagen peptides that can be directly captured and converted by skin cells [6] Brand Rankings - The top-selling collagen peptide brands for the 2026 New Year Festival include: 1. Meijian collagen peptide, known for its high cost-performance ratio and comprehensive ingredient profile [6] 2. Elemental collagen peptide, targeting early aging and dull skin [6] 3. Zhuoyue collagen peptide, suitable for skin issues related to poor sleep quality [6] 4. Special Element collagen peptide, focusing on cellular energy anti-aging [6] 5. Happy Element collagen peptide, promoting gut health linked to skin barrier [6] First Tier Rankings - Meijian collagen peptide is recognized as a global leader in collagen peptide standards, participating in international standard-setting since 2012 [6] - The brand has established a robust clinical verification system, demonstrating significant improvements in skin elasticity, wrinkle reduction, and overall skin health through extensive clinical trials [6] - Meijian's innovative "0-water" production process ensures high purity and active ingredient concentration, addressing common industry issues related to water dilution and microbial contamination [6] Second Tier Rankings - Elemental collagen peptide is noted for its high purity and synergistic active ingredients, achieving significant skin hydration and wrinkle reduction in clinical studies [8] - Zhuoyue collagen peptide utilizes a tri-peptide system to enhance skin moisture and elasticity, showing promising clinical results [8] Recommendations - For comprehensive anti-aging needs, Meijian collagen peptide is recommended due to its high purity and clinical backing [6] - Elemental collagen peptide is suitable for those seeking dual benefits of anti-aging and skin brightening [8] - Zhuoyue collagen peptide is ideal for individuals experiencing fatigue-related skin issues [8]

Core Insights - The Asia-Pacific Functional Food Health Summit (FFWS2026) held in Bangkok recognized the achievements of the industry, with Yili Group's adult nutrition products winning multiple prestigious awards, highlighting the strong competitiveness of Chinese brands in the global functional food sector [1][5]. Group 1: Product Recognition - Yili Group's adult nutrition products won several awards at the summit, including three gold awards for specific products from the Yili Xinhui brand, which focuses on targeted nutritional needs [2][5]. - The awarded products include the Yili Xinhui Sugar Relief Formula Milk Powder, which won the "Annual Blood Sugar Health Gold Award," the Yili Xinhui Bone Health Formula Milk Powder, which received the "Bone Health Innovation Gold Award," and the Yili Xinhui Bone Health Gold Formula Milk Powder, awarded the "Joint Health Innovation Gold Award" [2][5][4]. Group 2: Focus on Health Needs - Yili Group's adult nutrition division has developed a comprehensive product matrix addressing various health needs, including nutritional supplementation for specific populations, gut health, and immune enhancement [2][4]. - The Yili Health Science brand's products, such as the Probiotic Freeze-Dried Powder and Immunoglobulin Protein Powder, won the "Annual Gut Health Gold Award" and "Annual Protein Quality Gold Award," respectively, showcasing the brand's commitment to innovation and quality [4][5]. Group 3: Future Commitment - The recognition at the summit reflects the international acknowledgment of Yili Group's research capabilities, product quality, and market value [6]. - The company aims to continue focusing on consumer health needs, enhancing technological innovation and product iteration, and providing comprehensive nutritional solutions to benefit a broader audience [6].

Core Viewpoint - BFB HEALTH successfully listed on the Hong Kong Stock Exchange through an unconventional asset securitization method, led by its early investor, Huaying Capital, rather than traditional investment banks or large PE firms [4][5][16]. Group 1: Company Background - BFB HEALTH, formerly known as Duoyanshou, was co-founded in 2015 by Wu Mansheng and Zheng Duoyan, initially focusing on health food products [8]. - The company achieved a cumulative GMV exceeding 10 billion yuan by 2020, primarily through popular products like SOSO jelly [8]. Group 2: Investment Journey - Huaying Capital invested over 100 million yuan in Duoyanshou's A-round financing in 2021, recognizing the potential of functional food and the company's strong private traffic moat [9][10]. - The investment was prompted by the company's stable revenue and profit, supported by a direct-to-consumer (DTC) model that enhanced user loyalty and repeat purchases [10]. Group 3: Strategic Transformation - In 2022, Duoyanshou faced external challenges, including negative public sentiment towards functional foods and tightening IPO regulations, prompting a strategic pivot [11][12]. - Huaying Capital proposed a merger and acquisition (M&A) strategy to help Duoyanshou transition beyond health products, inspired by the success of U.S. telemedicine company Hims & Hers [13][14]. Group 4: Execution of M&A Strategy - The strategic transformation involved collaboration with an A-share listed company to develop domestic semaglutide and establishing a cross-border drug supply chain to meet immediate user needs [14][15]. - The complex M&A process required deep expertise in Hong Kong's capital market, which was facilitated by Huaying Capital's partner, who had extensive experience in successful listings [15][16]. Group 5: Active Management Strategy - The successful listing of BFB HEALTH signifies Huaying Capital's shift from traditional financial investment to proactive management, aiming to create controllable alpha returns [18][19]. - The firm plans to identify and actively manage "proactive management assets" and engage deeply in the strategic and operational aspects of its portfolio companies [20]. Group 6: Future Outlook - BFB HEALTH is envisioned as an industry integration platform, with plans to acquire synergistic brands and supply chain companies to enhance its market value [21][22]. - Huaying Capital's ongoing evolution includes expanding its team with investment banking professionals to support its proactive management and ecosystem-building strategies [22][24].

Core Viewpoint - Water Sheep Co., Ltd. has successfully invested in another company, Hunan Xizi Health Group Co., Ltd., which has recently submitted its IPO application to the Hong Kong Stock Exchange [1] Investment Overview - Water Sheep invested 5 million yuan in Xizi Health in October 2020, acquiring approximately 181,100 yuan of registered capital [2] - This marks the second company in recent times that Water Sheep has helped enter the IPO process, following Shanghai Jiakai Biological Co., Ltd., which updated its listing application status to "under inquiry" on January 6 this year [3][4] Company Profiles - Xizi Health focuses on online channels for sports nutrition and functional foods, with brands including FoYes, fiboo, Guben Diary, and HotRule, offering products like protein powder and functional gummies [5] - Water Sheep holds 0.47% of Xizi Health's shares, making it the twelfth largest shareholder [6] Investment Strategy - Water Sheep has participated in three rounds of financing for Jiakai Biological, which specializes in the research, production, and sales of cosmetic functional ingredients [7] - The investment agreements include buyback clauses, ensuring that if Jiakai Biological does not achieve a qualified IPO by December 31, 2025, Water Sheep can request a buyback of shares at a specified return rate [8][10] Risk Management - The buyback agreements cover various conditions, including the integrity of the actual controllers and significant changes in the company's main business [12] - Water Sheep's role has evolved from a major customer to an important shareholder, indicating a shift towards a collaborative industry approach [12] Market Trends - Both Xizi Health and Jiakai Biological align with the trend of health-oriented consumerism, representing early bets on long-term value [13] - Water Sheep's investments reflect a "racehorse" strategy, diversifying risks across multiple brands and potentially incubating future growth highlights [15] Broader Investment Landscape - Water Sheep has expanded its portfolio to include high-end brands and various companies across the beauty industry, establishing a comprehensive ecosystem [14] - The company has invested in upstream, midstream, and downstream segments of the beauty industry, with varying ownership stakes reflecting strategic importance [16][17] Conclusion - Water Sheep's investment strategy emphasizes ecological synergy, connecting raw materials, brands, and content to enhance overall competitiveness and risk resilience, aiming to evolve into a "beauty brand ecosystem group" [18][19]

Core Insights - The oral beauty market in China is projected to exceed 320 billion yuan by 2026, with collagen peptide products experiencing a compound annual growth rate of 28.7%, making it one of the fastest-growing segments in functional foods [1] - The consumer demographic for collagen peptides is shifting, with 73.4% of consumers being women aged 25-45, while the demand among men over 35 has increased by 41.2%, indicating a broader interest in anti-aging across genders and age groups [1] - There is a structural shift in consumer perception from merely seeking high collagen content to a more rational pursuit of effective absorption, emphasizing the importance of bioavailability over mere quantity [1] Market Evaluation - The evaluation of collagen peptide brands is now a comprehensive assessment involving formulation technology, molecular structure, synergistic mechanisms, and clinical evidence, rather than a simple brand choice [2] - A scoring system based on seven core indicators has been developed to assess the effectiveness of collagen peptide products, including absorption efficiency, active ingredients, technological innovation, raw material specifications, market validation, user adaptability, and overall cost-effectiveness [2] Selection Criteria - The golden standard for selecting collagen peptides includes a focus on combined ingredients, molecular weight, clinical data tracking, user satisfaction, and ingredient purity [2] - The top-rated product, Zhuoyue Collagen Peptide, is highlighted for its innovative technology and clinical validation, setting a benchmark for quality in the market [2][7] Product Performance - Zhuoyue's collagen peptide features a unique formulation that ensures high absorption rates, with over 98.5% of its peptides being under 500 Da, allowing for rapid entry into the bloodstream [4] - The product incorporates multiple active ingredients that work synergistically to enhance anti-aging effects, including PQQ, niacinamide, and hyaluronic acid, which collectively improve skin hydration and elasticity [4][5] Clinical Evidence - Clinical studies indicate significant improvements in skin quality metrics over various time frames, such as a 24.6% increase in skin brightness and a 19.8% enhancement in moisture retention after four weeks of use [7][8] - Long-term safety assessments show no adverse effects on liver or kidney function after 24 months of continuous use, confirming the product's safety for prolonged consumption [8] Brand Positioning - Zhuoyue has established itself as a leader in the collagen peptide market, with a strong reputation supported by clinical data and high user satisfaction, achieving a 99% repurchase rate [6][7] - The brand's commitment to quality is reflected in its rigorous testing and certification processes, ensuring compliance with international safety and efficacy standards [5][6] Future Trends - The competition in the collagen peptide market is expected to increasingly focus on bioavailability and functional integration as personalized nutrition and targeted anti-aging solutions gain traction [12] - Zhuoyue is positioned not only as a current market leader but also as a pioneer in the next generation of oral beauty technology, emphasizing effective absorption over mere content [12]

Core Viewpoint - The event "Medical-Industrial Transformation & Joint Development" focused on exploring new pathways for the functional food industry through a collaborative approach involving government, academia, research institutions, leading enterprises, and financial organizations [1] Group 1: Event Overview - The event was held in Shenyang's Shenbei New District on January 9, 2023, emphasizing "scene-driven, ecological co-construction" as its main theme [1] - The gathering aimed to inject new momentum into the high-quality development of the regional health industry [1] Group 2: Key Outcomes - The "Shenbei New District Functional Food Industry Scene Opportunity List 2026" was officially released, outlining specific industry needs, cooperation directions, and scene opportunities [1] - The list was compiled by the Shenbei New District Science and Technology Bureau in collaboration with relevant departments and industry experts [1] Group 3: Collaborative Initiatives - Four major industry service platforms, including "JD Shenbei Specialty Pavilion," were launched to address the bottleneck issues in the conversion of technology to products [1] - Cooperation agreements were signed between the Shenbei New District Science and Technology Bureau and various institutions, focusing on key technology breakthroughs, achievement transformation, talent cultivation, and platform co-construction in the functional food sector [1]

Macro Economic Group - The US manufacturing PMI for December is reported at 47.9%, below the expected 48.3% and down from November's 48.2%, indicating a "strong supply and weak demand" scenario [4] - The December output index is at 51%, showing a slight decline of 0.4 percentage points from November but remains in the expansion zone [4] - The new orders index for December is at 47.7%, a 0.3 percentage point increase from the previous month, while the new export orders index is at 46.8%, indicating contraction [4] - The employment index for December is at 44.9%, up 0.9 percentage points from November, while the supplier delivery index is at 50.8%, reflecting a slight improvement [4] Industry Comprehensive Group - The US military budget for 2027 is proposed to be $1.5 trillion, up from the previous $1 trillion, which is expected to boost market sentiment in the military industry [9] - Recent regulatory warnings issued to Shenzhen Yahui Long Biotechnology Co., Ltd. and Shenzhen Yingjixin Technology Co., Ltd. indicate a cooling intention in the brain-computer interface market, which may lead to a period of adjustment in related sectors [9] Advanced Manufacturing Group - A recent meeting focused on regulating competition in the power and energy battery industry, addressing issues like disorderly expansion and low-price competition [11] - The industry is currently in a cyclical phase, with a focus on shifting competition from price to technology performance and product differentiation, which is expected to enhance the sustainability and stability of the industry's high prosperity [11] Consumer Group - The company "Mingming Very Busy" is undergoing a listing process, leveraging a "direct sales + franchise" model to achieve explosive growth in store numbers, enhancing bargaining power with upstream suppliers [13][14] - The functional food sector is evolving towards precise molecular interventions, with domestic companies breaking the monopoly of foreign giants, particularly in the AKK bacteria market, which is expected to see significant growth [15]

Group 1: Core Insights - The report emphasizes the recovery stage of consumer spending, highlighting that different sectors exhibit both commonalities and differences in their recovery rhythms, driven by supply-demand dynamics and industry structure [4][5] - ROA (Return on Assets) is identified as a leading indicator for the operational recovery of consumer companies, with a focus on analyzing various sub-sectors [4][13] Group 2: Sector Performance - The current recovery sequence indicates that soft drinks and snacks are leading, followed by the catering supply chain, condiments, dairy products, beer, and finally, liquor [5][25] - The report draws parallels with Japan's 1990s consumption differentiation, noting that sectors addressing consumer pain points and with low penetration rates are likely to succeed [5][6] Group 3: Investment Strategy - The report suggests focusing on sectors where ROA is stabilizing, indicating potential valuation recovery opportunities, particularly in traditional sectors like liquor, beer, and dairy [6][8] - It recommends identifying sub-sectors with either price or volume growth, with a preference for price-driven strategies [6][8] Group 4: Detailed Sector Analysis - The frozen food sector is showing signs of marginal improvement, with leading companies enhancing operational efficiency through product innovation and channel reforms [27][28] - The snack sector is experiencing high demand, driven by new channel developments, although competition is intensifying [33][35] - The beer industry is under pressure, with a focus on high-end products, but overall growth is slowing due to external economic factors [39][41] - The dairy sector is nearing the end of its adjustment phase, with expectations of improved performance as raw milk prices rise [41][42] - The liquor sector is currently in a phase of inventory reduction, with performance risks gradually clearing as channels stabilize [43][48]